Wildiers H - Search Results

1

Combretastatin A-4 phosphate enhances CPT-11 activity independently of the administration sequence.

Wildiers H, Ahmed B, Guetens G, De Boeck G, de Bruijn EA, Landuyt W, van Oosterom AT. Wildiers H, et al. Eur J Cancer. 2004 Jan;40(2):284-90. doi: 10.1016/j.ejca.2003.09.006. Eur J Cancer. 2004. PMID: 14728944

2

Melphalan availability in hypoxia-inducible factor-1alpha+/+ and factor-1alpha-/- tumors is independent of tumor vessel density and correlates with melphalan erythrocyte transport.

Wildiers H, Guetens G, de Boeck G, Landuyt W, Verbeken E, Highley M, de Bruijn EA, van Oosterom AT. Wildiers H, et al. Int J Cancer. 2002 Jun 1;99(4):514-9. doi: 10.1002/ijc.10391. Int J Cancer. 2002. PMID: 11992540

3

Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.

Wildiers H, Guetens G, De Boeck G, Verbeken E, Landuyt B, Landuyt W, de Bruijn EA, van Oosterom AT. Wildiers H, et al. Br J Cancer. 2003 Jun 16;88(12):1979-86. doi: 10.1038/sj.bjc.6601005. Br J Cancer. 2003. PMID: 12799646 Free PMC article.

4

Pharmacology of anticancer drugs in the elderly population.

Wildiers H, Highley MS, de Bruijn EA, van Oosterom AT. Wildiers H, et al. Clin Pharmacokinet. 2003;42(14):1213-42. doi: 10.2165/00003088-200342140-00003. Clin Pharmacokinet. 2003. PMID: 14606930 Review.

5

Unexpected interactions between nicotinamide and CPT-11 in a rhabdomyosarcoma tumor model.

Wildiers H, Ahmed B, Guetens G, De Boeck G, De Bruijn EA, Landuyt W, Van Oosterom AT. Wildiers H, et al. Anticancer Res. 2003 Sep-Oct;23(5A):4055-9. Anticancer Res. 2003. PMID: 14666718

6

Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCR.

Ismail MS, Wynendaele W, Aerts JL, Paridaens R, Gaafar R, Shakankiry N, Khaled HM, Christiaens MR, Wildiers H, Omar S, Vandekerckhove P, Van Oosterom AT. Ismail MS, et al. Among authors: wildiers h. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):196-201. doi: 10.1158/1078-0432.ccr-0515-2. Clin Cancer Res. 2004. PMID: 14734470

7

Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II study.

D'hondt R, Paridaens R, Wildiers H, Pauwelyn K, Thomas J, Dumez H, Van Oosterom AT. D'hondt R, et al. Among authors: wildiers h. Anticancer Drugs. 2004 Apr;15(4):341-6. doi: 10.1097/00001813-200404000-00005. Anticancer Drugs. 2004. PMID: 15057137 Clinical Trial.

8

Vascular endothelial growth factor and angiogenesis.

Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Hoeben A, et al. Among authors: wildiers h. Pharmacol Rev. 2004 Dec;56(4):549-80. doi: 10.1124/pr.56.4.3. Pharmacol Rev. 2004. PMID: 15602010 Review.

9

Ecteinascidin-743: evidence of activity in advanced, pretreated soft tissue and bone sarcoma patients.

Huygh G, Clement PM, Dumez H, Schöffski P, Wildiers H, Selleslach J, Jimeno JM, Wever ID, Sciot R, Duck L, Van Oosterom AT. Huygh G, et al. Among authors: wildiers h. Sarcoma. 2006;2006:56282. doi: 10.1155/SRCM/2006/56282. Epub 2006 Dec 31. Sarcoma. 2006. PMID: 17496996 Free PMC article.

10

Mastering chemotherapy dose reduction in elderly cancer patients.

Wildiers H. Wildiers H. Eur J Cancer. 2007 Oct;43(15):2235-41. doi: 10.1016/j.ejca.2007.06.013. Epub 2007 Aug 7. Eur J Cancer. 2007. PMID: 17686626 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters